| Rank | Company | Net assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|---|
| 101 | $375M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 102 | $369M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 103 | $367M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 104 | $362M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 105 | $354M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 106 | $348M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 107 | $346M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 108 | $341M | Healthcare | Pharmaceuticals | United States | NYSE | |
| 109 | $332M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 110 | $329M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 111 | $324M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 112 | $324M | Healthcare | Pharmaceuticals | United States | NYSE | |
| 113 | $323M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 114 | $322M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 115 | $312M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 116 | $311M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 117 | $306M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 118 | $302M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 119 | $287M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 120 | $280M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 121 | $278M | Healthcare | Pharmaceuticals | United States | NYSE | |
| 122 | $277M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 123 | $271M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 124 | $269M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 125 | $266M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 126 | $262M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 127 | $259M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 128 | $256M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 129 | $254M | Healthcare | Pharmaceuticals | United States | NYSE | |
| 130 | $248M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 131 | $247M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 132 | $246M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 133 | $240M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 134 | $240M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 135 | $239M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 136 | $234M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 137 | $233M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 138 | $229M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 139 | $225M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 140 | $222M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 141 | $221M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 142 | $220M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 143 | $219M | Healthcare | Pharmaceuticals | United States | NYSE | |
| 144 | $219M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 145 | $218M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 146 | $217M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 147 | $217M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 148 | $215M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 149 | $211M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 150 | $210M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 151 | $207M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 152 | $205M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 153 | $204M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 154 | $202M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 155 | $195M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 156 | $191M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 157 | $186M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 158 | $183M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 159 | $177M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 160 | $175M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 161 | $173M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 162 | $172M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 163 | $172M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 164 | $169M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 165 | $165M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 166 | $164M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 167 | $163M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 168 | $149M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 169 | $148M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 170 | $147M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 171 | $144M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 172 | $144M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 173 | $139M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 174 | $139M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 175 | $138M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 176 | $136M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 177 | $134M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 178 | $131M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 179 | $128M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 180 | $128M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 181 | $128M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 182 | $127M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 183 | $125M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 184 | $120M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 185 | $120M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 186 | $114M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 187 | $108M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 188 | $106M | Healthcare | Pharmaceuticals | United States | NYSE | |
| 189 | $106M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 190 | $103M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 191 | $103M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 192 | $103M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 193 | $102M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 194 | $101M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 195 | $101M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 196 | $94.5M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 197 | $86.7M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 198 | $85.7M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 199 | $83.7M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 200 | $83.3M | Healthcare | Pharmaceuticals | United States | Nasdaq |